Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Evette Mitkov

MIRA Pharmaceuticals Stock Surges Following Positive Preclinical Data

chart

MIRA Pharmaceuticals Inc (NASDAQ:MIRA) shares are trading significantly higher on Thursday following the announcement of new preclinical data for its lead candidate Mira-55.

What Happened: MIRA announced preclinical study results showing that oral Mira-55 normalized pain and significantly reduced inflammation in an animal model of inflammatory pain, outperforming injected morphine.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.